Novel Chemotherapeutic Agents and Palliative Chemotherapy (2024 AC LIVE)

Only available as part of a package

Learning Objectives:

Upon completion, participant will be able to define Palliative Chemotherapy and goals of treatment.
Upon completion, participant will be able to articulate non-cytotoxic medications with disease altering properties which provide symptomatic relief.
Upon completion, participant will be familiar with non-cytotoxic target therapies that have anti-neoplastic effects.

Jason R. Beckrow, DO, FACOI, FAAHPM, HMDC (he/him/his)

Assistant Professor

Michigan State University

Dr. Beckrow completed his undergraduate education at the Lyman Briggs College of Michigan State University (MSU), attended medical school at MSU’s College of Osteopathic Medicine, completed an Internal Medicine internship and residency at Ingham Regional Medical Center and an Oncology Fellowship conducted through MSU and the Great Lakes Cancer Institute at the Breslin Cancer Center in Lansing, Michigan.

Dr. Beckrow is Board Certified in Internal Medicine and Hospice & Palliative Medicine. He is a Fellow of the American Academy of Hospice and Palliative Medicine (AAHPM), a Fellow of the American College of Osteopathic Internists (FACOI), and is Hospice Medical Director Certified (HMDC). Dr. Beckrow serves as an Associate Medical Director for Caring Circle – Corewell Health in St. Joseph, Michigan, Physician Faculty at Trillium Institute in Grand Rapids, Michigan, is an Assistant Professor for MSU’s College of Osteopathic Medicine, and serves as Medical Director for Hospice and Palliative Medicine at McLaren Greater Lansing. Dr. Beckrow enjoys being involved in many community organizations and is proud to serve on the Board of Education for Lakeshore Public Schools, and as a board member for the Boys and Girls Club of Southwest Michigan. In his spare time, Dr. Beckrow enjoys reading, hiking, and traveling with his wife, Kate, and their family.